These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 7836695)

  • 1. Within-individual reproducibility of a dual sample oral cholate challenge test (DuO) and simplified versions of the HepQuant SHUNT test.
    McRae MP; Kittelson J; Helmke SM; Everson GT
    Clin Transl Sci; 2024 Apr; 17(4):e13786. PubMed ID: 38558534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics.
    Davis M
    Clin Pharmacokinet; 2007; 46(10):825-50. PubMed ID: 17854233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose adjustment in patients with liver disease.
    Delcò F; Tchambaz L; Schlienger R; Drewe J; Krähenbühl S
    Drug Saf; 2005; 28(6):529-45. PubMed ID: 15924505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of opioids in liver disease.
    Tegeder I; Lötsch J; Geisslinger G
    Clin Pharmacokinet; 1999 Jul; 37(1):17-40. PubMed ID: 10451781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hepatic insufficiency on pharmacokinetics and drug dosing.
    Verbeeck RK; Horsmans Y
    Pharm World Sci; 1998 Oct; 20(5):183-92. PubMed ID: 9820880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.
    Morgan DJ; McLean AJ
    Clin Pharmacokinet; 1995 Nov; 29(5):370-91. PubMed ID: 8582120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine drug testing of chronic pain patients. V. Prevalence of propoxyphene following its withdrawal from the United States market.
    Puet B; DePriest A; Knight J; Heltsley R; Black DL; Caplan YH; Cone EJ
    J Anal Toxicol; 2013; 37(1):1-4. PubMed ID: 23129731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["To select better--to shunt better" prerequisites for better shunt therapy in liver cirrhosis. Review].
    Thiel H; Wolter J
    Fortschr Med; 1977 May; 95(17):1159-66. PubMed ID: 323127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propoxyphene and norpropoxyphene plasma concentrations after oral propoxyphene in cirrhotic patients with and without surgically constructed portacaval shunt.
    Giacomini KM; Giacomini JC; Gibson TP; Levy G
    Clin Pharmacol Ther; 1980 Sep; 28(3):417-24. PubMed ID: 7408401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanol interaction with propoxyphene and norpropoxyphene metabolism in isolated rat hepatocytes.
    Olsen H; Bodd E; Meyer T; Mørland J
    Pharmacol Biochem Behav; 1983; 18 Suppl 1():301-4. PubMed ID: 6634844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gas chromatographic determination of propoxyphene and norpropoxyphene in plasma.
    Cleemann M
    J Chromatogr; 1977 Feb; 132(2):287-94. PubMed ID: 833237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propoxyphene and norpropoxyphene plasma concentrations in the anephric patient.
    Gibson TP; Giacomini KM; Briggs WA; Whitman W; Levy G
    Clin Pharmacol Ther; 1980 May; 27(5):665-70. PubMed ID: 7371364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propoxyphene and norpropoxyphene tissue concentrations in fatalities associated with propoxyphene hydrochloride and propoxyphene napsylate.
    Baselt RC; Wright JA
    Arch Toxicol; 1975 Oct; 34(2):145-52. PubMed ID: 983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-propoxyphene and norpropoxyphene kinetics after the oral administration of D-propoxyphene: a new approach to liver function?
    Horsmans Y; Desager JP; Daenens C; Harvengt C; Geubel AP
    J Hepatol; 1994 Sep; 21(3):283-91. PubMed ID: 7836695
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.